Apollo Hospitals Enterprise Limited Share Price & Stock Analysis

Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP, BSE: 508869) is a Chennai, Tamil Nadu-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹1,23,712 Cr, it ranks #89 by market cap among the 6,197 Indian listed companies on FinBizNet, and #1 of 46 in Hospitals and Healthcare Centers. At ₹8,526.00 (as of 16 Nov 2026), the share price is 6.0% below its 52-week high of ₹9,070.50 and 27.3% above its 52-week low of ₹6,696.50. The share price is up 11.6% over one year and down 0.9% over three months.

Key Metrics

Current Price₹8,526.00
Market Cap₹1,23,712 Cr
NSE SymbolAPOLLOHOSP
BSE Code508869
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Hospitals and Healthcare Centers
P/E Ratio63
Return on Equity21.50%
Return on Assets8.47%
52-Week Range₹6,696.50 – ₹9,070.50
1-Year Price Change+11.6%
3-Month Price Change-0.9%
Beta (1Y)0.28
Dividend Yield0.24%
HeadquartersChennai, Tamil Nadu
Websitewww.apollohospitals.com

Latest Quarterly Results — Q2 FY27

Revenue₹7,615 Cr
Net Profit₹660 Cr
Net Margin8.7%
EPS (Basic)₹43.74
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Apollo Hospitals Enterprise Limited Quarterly Revenue and Profit Trend

Apollo Hospitals Enterprise Limited reported revenue of ₹7,615 Cr in Q2 FY27, up 20.8% from ₹6,304 Cr in Q2 FY26 and up 8.1% from ₹7,044 Cr in Q1 FY27. It posted a net profit of ₹660 Cr for the quarter, against a net profit of ₹494 Cr in Q2 FY26 (up 33.5%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹5,592 Cr (Q4 FY25) to ₹7,615 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹7,615 Cr₹660 Cr8.7%
Q1 FY27₹7,044 Cr₹610 Cr8.7%
Q4 FY26₹6,606 Cr₹551 Cr8.3%
Q3 FY26₹6,477 Cr₹516 Cr8.0%
Q2 FY26₹6,304 Cr₹494 Cr7.8%
Q1 FY26₹5,842 Cr₹441 Cr7.5%
Q4 FY25₹5,592 Cr₹415 Cr7.4%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 28.02% of Apollo Hospitals Enterprise Limited's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 55.6% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company’s healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent f

Products and Services

1. Healthcare Services-This segment operates hospitals and hospital based pharmacies. 2. Apollo Digital 24/7 Business-This segment operates pharmacy retail outlets. 3. Clinics-This segment operates clinics. 4. Others-This segment holds investments and fixed deposits.

Business Segments

1. Healthcare Services-50.5% 2. Retail Health & Diagnostics-7.4% 3. Digital Health & Pharmacy Distribution-42.8% 4. Others-0%

Apollo Hospitals Enterprise Limited vs Peers — Hospitals and Healthcare Centers

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Apollo Hospitals Enterprise Limited₹1,23,712 Cr6321.50%₹7,615 Cr+11.6%
Max Healthcare Institute Ltd₹91,978 Cr63.914.33%₹2,569 Cr-16.6%
Manipal Health Enterprises Ltd₹89,110 Cr88.4—₹3,399 Cr—
Aster Dm Healthcare Limited (Asterdm)₹63,041 Cr97.610.07%₹2,829 Cr+4.3%
Fortis Healthcare Ltd.₹58,283 Cr55.111.01%₹2,735 Cr-25.1%
Global Health Ltd (Medanta)₹38,422 Cr69.715.03%₹1,469 Cr+16.2%
Narayana Hrudayalaya Limited₹37,907 Cr46.219.85%₹2,844 Cr+2.8%
Krishna Institute Of Medical Science (KIMS)₹29,056 Cr120.69.72%₹1,344 Cr+0.2%
Dr. Agarwal's Health Care Limited₹17,568 Cr131.98.31%₹655 Cr+9.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Apollo Hospitals Enterprise Limited?

Apollo Hospitals Enterprise Limited is trading at ₹8,526.00, with a market capitalisation of ₹1,23,712 Cr.

Which sector does Apollo Hospitals Enterprise Limited belong to?

Apollo Hospitals Enterprise Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).

What are the key financial ratios of Apollo Hospitals Enterprise Limited?

Apollo Hospitals Enterprise Limited has a P/E of 63 and a return on equity of 21.50%.

What is the stock symbol of Apollo Hospitals Enterprise Limited?

Apollo Hospitals Enterprise Limited is listed on the NSE under the symbol APOLLOHOSP and on the BSE under the scrip code 508869.

How has Apollo Hospitals Enterprise Limited's share price moved over the past year?

Apollo Hospitals Enterprise Limited's share price is up 11.6% over one year and down 0.9% over three months. Its 52-week range is ₹6,696.50 to ₹9,070.50.

What were Apollo Hospitals Enterprise Limited's latest quarterly results?

In Q2 FY27, Apollo Hospitals Enterprise Limited reported revenue of ₹7,615 Cr and net profit of ₹660 Cr, with basic EPS of ₹43.74 (consolidated, parsed from the company's exchange filing).

How have Apollo Hospitals Enterprise Limited's revenue and profit changed over the past year?

Apollo Hospitals Enterprise Limited reported revenue of ₹7,615 Cr in Q2 FY27, up 20.8% from ₹6,304 Cr in Q2 FY26 and up 8.1% from ₹7,044 Cr in Q1 FY27.

What is the promoter holding in Apollo Hospitals Enterprise Limited?

Promoters held 28.02% of Apollo Hospitals Enterprise Limited's shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.